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Objective: Despite the high prevalence of malnutrition in the general inpatient population, there is
a lack of knowledge in regard to detecting disease-related malnutrition and implementing nutri-
tional support. Our aim was to suggest practical procedures for screening and treating malnour-
ished or at-risk patients hospitalized in medical wards, thereby fostering a straightforward
implementation of nutritional therapy independent of the underlying disease and comorbidities.
Methods: A working group of experts in clinical nutrition selected and analyzed published disease-
specific European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines relevant for our
aim. Eight questions in population, intervention, control, outcome format were defined to cover
topics such as screening, nutritional targets, and routes of feeding. Individual studies were
extracted from the guidelines by applying inclusion and exclusion criteria targeting the hetero-
geneous population of medical inpatients with or at-risk of disease-related malnutrition. We used
those studies as evidence, as well as recommendations from the selected ESPEN guidelines, to
formulate answers to the questions. Final agreement with the statement was obtained by
consensus of the whole working group.ank warmly all member of
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L. Bounoure et al. / Nutrition 32 (2016) 790–798 791Results: Procedures on how to provide integrated nutritional therapy (oral, enteral, and parenteral)
to a heterogeneous patient population were suggested, including how to identify malnourished or
at-risk patients, nutrient targets, choice of feeding route, monitoring, and assessment of patients.
We also developed a simple algorithm to facilitate the implementation of a nutritional care plan for
the general medical inpatient population.
Conclusion: By compiling evidence and recommendations from disease-specific guidelines, we
were able to suggest a nutritional strategy applicable to large and heterogeneous group of
malnourished or at-risk patients admitted to hospitals. A large randomized controlled trial is
currently investigating whether this strategy improves clinical outcomes of patients.
 2016 Elsevier Inc. All rights reserved.Introduction
Patients admitted to medical wards of hospitals, for instance
after an acute exacerbation of a chronic condition, are at high risk
to have or develop disease-related malnutrition (DRM) resulting
from loss of appetite, poor nutritional intake, and disease-related
catabolism [1,2]. If untreated, DRM ultimately leads to significant
loss of lean and adipose tissues and affects the function and re-
covery of multiple organ systems [3]. Among hospitalized pa-
tients, the prevalence of DRM is estimated between 20% and 55%,
with about 20% of patients affected in Switzerland [4–7]. Hos-
pitalized elderly patients are particularly vulnerable to develop
DRM as a consequence of preexisting decreased lean body mass
and impaired intake of protein, energy, and fluids [8]. DRM in
turn has profound effects on disease course and recovery [9,10].
Several clinical studies have linked DRM to a higher morbidity,
mortality, risk of infection, longer stay in the hospital, and higher
costs [11]. In addition, several randomized controlled trials
(RCTs) found beneficial effects associated with nutritional ther-
apy in the malnourished inpatient population. In fact, a recent
meta-analysis focusing on nutritional support in the medical
inpatient population found nutritional interventions to be
associated with high intake of energy and protein and an in-
crease in body weight [12]. Risk for unplanned readmission after
hospital discharge was significantly decreased as was length of
stay in the malnourished population.
Current guidelines published by the European Society for
Clinical Nutrition and Metabolism (ESPEN) provide primarily
recommendations for nutritional therapy specific to particular
organ dysfunctions and medical specialty (e.g. liver, oncology,
and geriatrics). Yet, those recommendations are often neglected
and or not implemented in the large and highly heterogeneous
medical inpatient population of medical wards. This may be one
of the reasons why, in many medical wards of hospitals, no
systematic screening and nutritional therapy programs are
currently in place, which contributes to the alleged undertreat-
ment of patients with this condition. A study from 2010,
including patients admitted to the departments of internal
medicine of seven Swiss hospitals during a 3 years period,
showed that among those with a strong indication for nutrition
therapy, only 70% obtained nutritional interventions.
We created a multiprofessional working group composed of
experts in clinical nutrition, used current ESPEN guidelines, and
the research findings they were built on, to establish a consensus
on how to provide nutritional therapy to the heterogeneous
malnourished or at-risk medical inpatient population. We detail
our rationale and supporting evidence for our suggestions and
present them as an algorithm to enable easy and quick decision
making for nutritional therapy for general medical inpatients
with or at-risk of DRM. The present study was carried out inpreparation for a large-scale, Swiss-wide, multicenter RCT
(https://clinicaltrials.gov/ct2/show/NCT02517476) in a mixed
internal medicine population, where the proposed algorithm is
currently being validated.
Methods and materials
A working group of experts in clinical nutrition was formed (see Acknowl-
edgment section). During a workshop that took place in Basel, Switzerland, on
February 21, 2014, a subworking group selected ESPEN guidelines specific to
diseases and medical specialties (e.g. liver disease and oncology) to be used as a
source of supporting evidence relevant to the patient population of general
medical inpatients (Appendix A available online at www.nutritionjrnl.com).
Guidelines for the geriatric population were also considered since a large part of
malnourished or at-risk patients in medical wards of hospitals are elderly (i.e.
over 75 y old). All guidelines we selected were updated for the last time in 2006
and 2009 (guidelines for enteral and parenteral nutrition, respectively). The
subworking group also defined topics of interest to be covered in the suggested
procedures (such as screening method, energy, protein, micronutrient and other
nutritional targets, route of feeding). Eight clinical questions in population,
intervention, control, outcome format were developed to address those topics.
In a second step, we defined inclusion and exclusion criteria applying to
participants, outcomes and study design to explore the evidence behind the
selected ESPEN guidelines (Appendix B available online at www.nutritionjrnl.
com). Thereafter, we screened the abstracts of the studies found in the ESPEN
guidelines and selected those that met our inclusion criteria and provided an-
swers to our questions. The years of publication (1982–2007), design, number,
and main diagnostic of patients of each included study are reported in Table 1.
Recommendations applying to at-risk or malnourished patients found in the
selected ESPEN guidelines and providing answers to each of our clinical questions
were also extracted and are presented in Appendix A available online at www.
nutritionjrnl.com. For each clinical question, we formulated statements based
on 1) the analysis of the studies we selected from the ESPEN guidelines (Table 1),
and 2) the recommendations found in those guidelines (Appendix A available
online at www.nutritionjrnl.com).
Statements were presented in a table (Table 2) that was sent by email to all
members of theworking group. Themembers were asked to express their level of
agreement with each statement by choosing between a “strong” (i.e. we
recommend or “should”) or “weak” (we suggest or “may”) agreement and by
providing a rationale supporting their opinion. After collecting all agreements,
statements were adapted according to their associated predominant level and a
final consensus procedure on the detection and treatment of malnutrition in
medical inpatients was suggested.We developed ultimately a nutrition algorithm
to display our conclusions in a graphical format (Fig. 1).
Results
Indication
Question 1. Is the Nutritional Risk Screening 2002 (NRS) an
appropriate tool to identify inpatients who are malnourished or at
risk for malnutrition, and predict positive outcome if followed by
nutritional support, when compared to other validated methods?
Although there is no universally accepted definition of
malnutrition, several nutritional screening and assessment tools
have been developed to detect the risk of DRM and/or existing
DRM in hospitalized patients.
Table 1
Studies extracted from selected ESPEN guidelines and used to answer each clinical question
Search
question
Source, year Studies included (author, year) Study design Participants (main diagnostic, N)
Question 1 ESPEN Guidelines for
Nutrition Screening 2002, 2003
Kondrup et al., 2003 Retrospective analysis Various acute illnesses, 8944
ESPEN Guidelines for
Nutrition Screening 2002, 2003
Johansen et al., 2003 RCT Various diagnostics, 212
Question 2 ESPEN Guidelines for
Nutrition Screening 2002, 2003
Johansen et al., 2003 RCT Various diagnostics, 212
ESPEN Guidelines on
Enteral Nutrition: Liver disease, 2006
Mendenhall 1993 Non-randomized trial Severe alcoholic hepatitis, 273
Kerns 1992 RCT Alcoholic liver disease, 31
ESPEN Guidelines on Enteral
Nutrition: Cardiology and Pulmonology, 2006
Heymsfield 1989 Non-randomized trial Congestive heart failure, 8
Ferreira 2012 Systematic review Obstructive pulmonary disease, 325
ESPEN Guidelines on Enteral
Nutrition: Non-surgical oncology, 2006
Ollenschläger 1992 RCT Acute leukemia, 29
Question 3 ESPEN Guidelines on Enteral
Nutrition: Adult Renal Failure, 2006
Schneeweiss 1990 Non-randomized trial Acute renal failure, 86
ESPEN Guidelines on Enteral
Nutrition: Non-surgical oncology, 2006
Knox 1983 Observational study Cancer, 200
Dempsey 1984 Observational study Gastrointestinal cancer, 173
ESPEN Guidelines on Enteral
Nutrition: Gastroenterology, 2006
Klein 1988 Observational study Ulcerative colitis, 8
ESPEN Guidelines on Enteral
Nutrition: Pancreas, 2006
Dickerson 1991 Observational study Acute pancreatitis, 48
ESPEN Guidelines on Parenteral
Nutrition: Hepatology, 2009
John, W.J., 1989 Non-randomized trial Alcoholic hepatitis, 20
Madden 1999 Non-randomized trial Alcoholic hepatitis, 141
ESPEN Guidelines on Enteral
Nutrition: Cardiology and Pulmonology, 2006
Poehlman 1994 Non-randomized trial Congestive heart failure, 60
Question 4 ESPEN Guidelines on Enteral
Nutrition: Gastroenterology, 2006
Klein 1988 Observational study Ulcerative colitis, 8
ESPEN Guidelines on Enteral Nutrition:
Wasting in HIV and other chronic
infectious diseases, 2006
Selberg 1995 Non-randomized trial HIV, 6
ESPEN Guidelines on Enteral
Nutrition: Liver disease, 2006
Bunout 1989 RCT Alcoholic liver disease, 36
Calvey 1985 RCT Alcoholic hepatitis, 64
ESPEN Guidelines on Parenteral
Nutrition: Hepatology, 2009
Swart 1989 Non-randomized trial Liver cirrhosis, 8
Nielsen 1993 Observational study Alcoholic liver cirrhosis, 37
Question 5 ESPEN Guidelines on Enteral
Nutrition: Pancreas, 2006
Du 2003 RCT Acute pancreatitis, 84
ESPEN Guidelines on Parenteral
Nutrition: Pancreas, 2009
Siriwardena 2007 RCT Acute pancreatitis, 43
ESPEN Guidelines on Enteral Nutrition:
Non-surgical oncology, 2006
Fearon 2003 RCT Cancer, 200
Bruera 2003 RCT Cancer, 60
Gogos 1998 RCT Cancer, 30
Question 6 ESPEN Guidelines on Enteral
Nutrition: Geriatrics, 2006
Milne 2002 Systematic review Geriatrics, 2464 (of whom 1623
unwell, 854 undernourished)
Milne 2006 Meta-analysis Geriatrics, 9187
Potter 2001 RCT Various diagnostics, geriatrics, 381
McEvoy 1982 RCT Various diagnostics, geriatrics, 51
Volkert 1996 RCT Various diagnostics, geriatrics, 46
ESPEN Guidelines on Enteral Nutrition:
Cardiology and Pulmonology, 2006
Saudny-Unterberger 1997 RCT Acute Exacerbation of Chronic Obstructive
Pulmonary Disease, 33
Question 7 ESPEN Guidelines on Enteral
Nutrition: Pancreas, 2006
Pandey 2004 RCT Acute pancreatitis, 28
Question 8 ESPEN Guidelines on Parenteral
Nutrition: Pancreas, 2009
Marick 2004 Meta-analysis Acute pancreatitis, 263
RCT, randomized controlled trial
L. Bounoure et al. / Nutrition 32 (2016) 790–798792The NRS is a nutrition screening tool that includes the eval-
uation of nutritional risk, disease severity and age of the patient.
It was developed based on a retrospective analysis of 128 RCTs of
nutritional therapy versus no therapy on clinical outcome in
hospitalized patients [13]. This analysis suggested that the NRS
was able to identify patients at risk of malnutrition and to
determine who would or would not benefit from nutritional
support, being a score of at least 3 indicative of a increased risk of
DRM and potential benefits from nutritional interventions. The
trials included in the study were performed in clinically het-
erogeneous groups of patients including surgical, critically ill,
and long-term care patients. Following this retrospective anal-
ysis, a prospective RCT focusing on 212 patients, predominantly
hospitalized on medical wards (68% of the included patients)was conducted. The NRS enabled to identify individuals at risk of
DRM, yet the intervention did not result in significant effects on
complications rate, length of hospital stay or quality of life (QoL),
questioning therefore the capacity of the NRS to predict positive
outcomes following nutritional therapy in the medical inpatient
population [14].
For the hospital setting, ESPEN recommends using the NRS
to determine the risk of malnutrition within 48 h post-
admission [15]. Most disease and organ-specific selected
guidelines, however, do not provide recommendation on the
choice of malnutrition screening and assessment tools, rather
relying on weight loss or BMI to identify patients at risk of
malnutrition. Those parameters are also commonly used to
diagnose DRM.
Table 2
Consensus opinion on nutritional therapy for general patients in medical wards of hospitals
Topics Recommendations Agreement
Indication The NRS should be used in medical wards to identify patients at risk of malnutrition (i.e. with a score of at
least 3 points), within 48 h post–hospital admission. A full nutritional assessment (including an in-depth evaluation
of anthropometric, biochemical, clinical, and dietary information) should be performed in patients with an NRS 3 to
determine if the patient is truly malnourished, to understand the causes of malnutrition and thus to support the
development of a tailored nutrition care plan.
Strong
Nutritional therapy should be considered in malnourished or at-risk medical inpatients for at least 5 to 7 d in
order to improve nutrition-related outcomes.
Strong
Energy and protein
requirements
REE should be individually measured by indirect calorimetry. Strong
When indirect calorimetry cannot be used, we suggest calculating REE with the body weight-adjusted
Harris-Benedict formula as long as clinical judgment and experience is also used to determine the final caloric targets.
Weak
Intakes of protein increased to at least 1.2 g/kg BW/d should be provided to correct or prevent protein malnutrition
in malnourished or at-risk medical inpatients.
Strong
We suggest lowering the protein intake to 0.8 to 1 g/kg BW/d for patients with acute and chronic renal failure
without renal replacement therapy.
Weak
Micronutrients and
other nutrients
requirements
We suggest supplementing malnourished or at-risk medical inpatients on oral nutrition with multivitamins and
multiminerals to reach the recommended dietary allowance for micronutrients, thereby correcting or preventing
deficiencies. However, an individual assessment of patients remains crucial to specifically correct deranged
values of micronutrients.
Weak
Additional oral
supplementation
ONS should be used in addition to hospital meals ideally adapted to individual preferences, to meet nutritional
requirements and improve outcomes of malnourished or at-risk medical inpatients. Fortification of meals and
providing patients with between-meal snacks should be at least equally part of the strategy to supplement intakes.
Strong
Route, monitoring
and reassessment
Enteral tube feeding, ideally maintaining some oral food intake, should be implemented in medical inpatients
with or at-risk of DRM who could not reach 75% of their energy and protein targets (or consume more than 75% of
the food served daily) within 5 d of oral feeding and for whom clinical judgment predicted that oral nutrition
would not be sufficient to improve nutritional intakes. Intakes should be reassessed every 24 to 48 h.
Strong
We recommend starting parenteral nutrition with a minimal oral or enteral feeding when possible, if oral and/or
enteral nutrition is not possible or if at least 75% of energy and protein targets have not been reached during the 5 d
following the beginning of enteral nutrition. Intakes should be reassessed every 24 to 48 h
Strong
BW, body weight; d, days; DRM, disease-related malnutrition; ONS, oral nutritional supplements; NRS, Nutritional Risk Screening; REE, resting energy expenditure
L. Bounoure et al. / Nutrition 32 (2016) 790–798 793Based on the available evidence, the NRS should be used in
medical wards to identify patients at risk of malnutrition and
start nutritional therapy in patients with a score of at least 3
points within 48 h post hospital admission. Yet, the NRS is not
intended to establish the diagnosis of existing malnutrition.
When possible, a full nutrition assessment (including an in-
depth evaluation of anthropometric, biochemical, clinical, and
dietary information) should be performed in patients with an
NRS 3 to determine if the patient is truly malnourished, to
understand the causes of malnutrition, and thus to support the
development of a tailored nutrition care plan. The recently
diagnostic criteria proposed by ESPEN may be considered [16].
On the other hand, uncertainty remains about whether or not at-
risk medical inpatients receiving nutritional therapy will indeed
benefit from this intervention. This topic is covered by the next
question.
Question 2. In malnourished or at-risk medical inpatients, does
nutritional therapy result in improved outcomes when compared
with usual care?
Studies describing any type of nutritional therapy in-
terventions (oral, enteral, or parenteral) in medical inpatients
with or at-risk of DRM were considered.
From six studies extracted, 1 systematic review of 325 pa-
tients showed weight gain and improved health-related QoL
(measured by St George’s Respiratory Questionnaire) in patients
with chronic obstructive pulmonary disease (COPD) receiving
oral, enteral, or parenteral feeding versus control [17]. We found
three RCTs, two of which confirmed positive effects of nutritional
therapy on weight stabilization (31 randomized patients with
alcoholic hepatitis fed by the enteral route) [18] and weight gain
(29 patients with acute leukemia receiving dietary counselling)
[19]. The third found no effect in 212 patients with various dis-
eases receiving dietary counselling and tailored nutritional
support [14]. In the same study, the intervention resulted inincreased protein and energy intake. One very small non-
randomized trial from 1989 performed on eight patients with
congestive heart failure treated with enteral feeding resulted in
gain of lean body mass but loss of weight [20]. In the sixth study,
a non-randomized trial of 273 patients with alcoholic hepatitis
receiving high-calorie, high-protein supplements with oxan-
drolone versus low-calorie, low-protein supplements without
the drug, reduction of mortality, severity of disease and malnu-
trition was observed [21]. None of the studies included demon-
strated effects of nutritional therapy interventions on length of
stay (LOS) [14] or prevention of infection [19].
Due to inconsistent results and/or the lack of well-designed
high-quality evidence, some of the disease-specific guidelines
we selected are not providing recommendations about nutri-
tional therapy in malnourished or at-risk patients. Available
recommendations, however, consistently support this practice to
improve nutritional status. Nutritional therapy is also recom-
mended to improve other outcomes in particular groups of pa-
tients (e.g., improve survival in liver failure or geriatric patients).
Based on the limited available evidence and recommenda-
tions found in selected guidelines, there is a good rationale that
nutritional therapy should be considered in malnourished or at-
risk medical inpatients for at least 5 to 7 d in order to improve
nutrition-related outcomes. More studies are needed in this
group of patients to better understand if other outcomes can be
improved in general medical inpatients (e.g. clinical, health re-
sources and patient-centered outcomes).
Energy and protein requirements
Question 3. In malnourished or at-risk medical inpatients,
should the gold-standard method indirect calorimetry be used to
determine individual energy requirements, when compared with
predictive equations?
Fig. 1. Nutritional algorithm: graphical representation of the suggested procedures.
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L. Bounoure et al. / Nutrition 32 (2016) 790–798 795Energy requirements of hospitalized patients differ depend-
ing on total energy expenditure, which is largely affected by the
body size, composition, as well as type and severity of disease.
Indirect calorimetry is the gold standard method to determine
total energy expenditure by measuring resting energy expendi-
ture (REE) and including energy expenditure linked with phys-
ical activity and consumption of food [22,23]. However, the costs,
availability, and practical considerations (e.g., requirement of
trained personal to perform measurements or fasting periods
before measurement) impose major barriers in using this
method and might explain its underuse often observed in
medical wards of hospitals [24]. The Harris-Benedict equation is
more frequently used in hospitals to calculate REE and estimate
caloric requirements, taking in consideration activity and stress
factors. In under- and overweight patients, this equation does
not enable precise calculation of REE. Using the Harris-Benedict
equation with adjusted body weight (BW) calculated with the
formula adjusted BW ¼ (actual BW - ideal BW) x 25% þ ideal BW
might improve its accuracy, although it is still unclear how to
ideally adjust BW in patients with a body weight outside of the
normal range [25].
We found eight studies among the guidelines assessing REE in
groups of malnourished or at-risk medical inpatients with
various acute illnesses (acute renal failure [26], cancer [27,28],
ulcerative colitis [29], acute pancreatitis [30], alcoholic hepatitis
[31,32], congestive heart failure [33]). Among them, we found six
studies (four observational studies [2730] and two
non-randomized trials [31,32]), in which REE was measured by
indirect calorimetry and compared to the value predicted by
Harris-Benedict formula. The formula failed to accurately predict
REE in all studies. In addition, of the eight studies extracted, four
non-randomized trials showed an increase REE of 42% [26], 55%
[29], 6% [30], and 18% [33] for inpatients, compared to healthy
controls.
If recommendations given by ESPEN for energy intakes are
different for each disease type, indirect calorimetry is invariably
suggested as the method of choice to determine energy targets.
Because the total energy expenditure of malnourished or at-
risk patients hospitalized in medical wards varies largely
among this heterogeneous group, REE should be individually
measured by indirect calorimetry to enable an accurate calcu-
lation of the energy requirements. However, when this method
cannot be used, we suggest calculating REE with the body
weight-adjusted Harris-Benedict formula as long as clinical
judgement and experience is also used to determine the final
caloric targets.
Question 4. In malnourished or at-risk medical inpatients, do
increased protein intakes result in improved outcomes, when
compared with usual care?
Protein needs are generally increased in case of illness and
hospitalization as a compensation for higher protein breakdown
and to limit loss of total body proteinmass andmalnutrition [34].
A total of six studies from the selected guidelines met our
selection criteria and were included. One observational study of
eight ulcerative colitis patients suggested that intakes of at least
1.4 g/kg BW/d are necessary to achieve nitrogen equilibrium [29].
In another small sample of six HIV patients, parenteral feeding
supplying at least 1.2/kg BW/d of protein enabled patients to
reach a positive nitrogen balance [35]. Of four studies conducted
on individuals with liver disease [3639], two studies (one
observational of 37 patients [36] and one non-RCT of eight pa-
tients [37]) showed that patients receiving hospital diet
providing 1.2 g of protein/kg BW/d achieved positive nitrogen
balance. Improved physical conditionwas also found in the smallnon-RCT [37]. One RCT of 36 patients found that oral diet
providing 1.5 g of protein/kg BW/d had no effect on mortality,
complications, or nutritional status [38]. The fourth study, an RCT
of 64 patients from 1985 showed that protein supplementation
of 65 g/day resulted in a positive nitrogen balance, but higher
complication rates and no effect on mortality [39]. It is however
impossible to assess the amount of protein per kilogram of BW
that those patients received. Consistent with our findings, most
selected guidelines recommend higher protein intakes (at least
1.2 g/kg BW/d). If malnutrition is diagnosed, including in elderly
individuals, the ESPEN recommended protein intakes are further
increased to 1.2 to 1.5 g protein/kg BW/d.
Intakes of protein increased to at least 1.2 g/kg BW/d should
be provided to correct or prevent protein malnutrition in
malnourished or at-risk medical inpatients. More studies are
needed to draw conclusions about the clinical benefits of
increased protein intake and optimal amounts to treat different
diseases.
Detrimental effects of high protein consumption on kidneys
have been demonstrated [40]. Defining the protein targets of
patients with or at risk of DRM and with altered kidney function
is challenging, particularly for elderly patients, whose protein
needs are further increased, creating a paradox difficult to handle
for clinicians. Interestingly, soy-based proteins might be less
harmful for kidneys [41], although their use is still controversial
and requires more RCTs to be implemented safely [42].
No study from the ESPEN guidelines for acute renal failure
patients met our inclusion criteria because a large majority was
performed on intensive care patients. Based on the recommen-
dations found in ESPEN guidelines and clinical judgement, we
suggest lowering the protein intake to 0.8 to 1 g/kg BW/day for
at-risk or malnourished medical inpatients with acute and
chronic renal failure without renal replacement therapy.
Micronutrients and other nutrients requirements
Question 5. In malnourished or at-risk medical inpatients, does
the supplementation of vitamins, minerals, and/or other nutrients
(e.g. n-3 fatty acids and branched amino-acids) result in improved
outcomes, when compared with usual care?
Electrolytes and vitamins deficiencies are common in patients
with or at-risk of DRM with acute diseases requiring hospitali-
zation in medical wards [43]. Furthermore, overfeeding of those
patients can result in refeeding syndrome, also creating or
worsening micronutrient deficiencies. Providing patients with
supplementation (such as multivitamin, multimineral, or
micronutrient supplements) might help prevent or correct
existing deficiencies. Due to their anti-inflammatory properties,
n-3 fatty acids supplementation might also be beneficial in some
hospitalized patients.
We found two studies investigating micronutrient supple-
mentation in medical inpatients with or at risk of DRM. Both
were recent RCTs studying acute pancreatitis patients for the
effects of high-dose vitamin C and vitamin C in combinationwith
selenium and n-acetylcystein, respectively. The first study was
performed on 84 patients and showed increased recovery rate,
improved cellular immune function as well as reduced rate of
complications and LOS in the intervention group [44]. In the
second study of 43 patients, vitamin C, selenium, and n-ace-
tylcystein treatment did not improve organ function, mortality,
and LOS and did not reduce oxidative stress [45]. Three other
RCTs investigated the effect of n-3 fatty acids supplementation in
oncology patients. In one study of 200 patients from 2003,
supplementation resulted in weight gain, increased lean body
L. Bounoure et al. / Nutrition 32 (2016) 790–798796mass, and improvement of QoL [46]. None of the two other RCTs
of 60 and 30 patients conducted in 2003 and 1998, respectively,
reported beneficial effects on weight and functional status
[47,48]. Additionally, no effect could be detected on appetite,
nausea, tiredness, overall sensation of well-being, caloric intake,
lean body mass [47], or survival rates [48] on supplemented
patients.
The supporting evidence regarding vitamins, minerals, or
other nutrients’ supplementation on outcomes is limited to
particular groups of patients (pancreatitis and cancer) and nu-
trients (vitamin C and n-3 fatty acids). It is therefore difficult to
extrapolate those findings to general medical inpatients. Based
on recommendations found in most selected guidelines, we
suggest supplementing malnourished or at-risk medical in-
patients with multivitamins and multiminerals to reach the
recommended dietary allowance for micronutrients, thereby
correcting or preventing deficiencies. Patients fed with enteral
nutrition are addressed in question 7. Furthermore, an individual
assessment of patients is needed in order to specifically correct
out-of-norm values of micronutrients. No recommendations for
supplementation with other nutrients (e.g. n-3 fatty acids) can
currently be made based on available evidence.
Additional oral supplementation
Question 6. In malnourished or at-risk medical inpatients, does
additional oral supplementation (e.g. oral nutritional supplements
(ONS) and fortified meals) result in improved outcomes, when
compared with standard care?
We identified five studies that explored the effect of ONS in
at-risk or malnourished medical inpatients (elderly with various
acute illnesses) and one in patients hospitalized for an acute
exacerbation of COPD.
In a Cochrane review from 2002, the subgroup analysis of
“unwell” (n ¼ 1623) or “undernourished” (n ¼ 854) elderly pa-
tients demonstrated beneficial effects of ONS on mortality
reduction [49]. In a subsequent meta-analysis from the same
author published in 2006 [50], supplementation of undernour-
ished hospitalized elderly individuals reduced mortality and
complications, improved nutritional status, but had no effect on
LOS. Three other studies (RCTs) consistently found nutritional
intake improvements and overall status of hospitalized elderly
patients who received ONS [5153]. Two of those studies [51,53]
additionally reported improved functional status, and one also
showed reduced risk of mortality, but no difference in LOS [51].
In a RCT conducted in 33 COPD patients, supplementation
with ONS or extra snacks in addition to the hospital diet resulted
in increased forced vital capacity, protein, and energy intakes,
but no significant changes were observed in other functional and
nutritional parameters.
None of these RCTs have analyzed data based on both protocol
analysis and intention to treat analysis. Among the RCTs included
in the systematic reviews, some studies reported that partici-
pants were excluded from the analysis because they felt unable
to take the supplements, but the analysis of outcomes on an
intention to treat basis was overall deficient. Poor compliance
with ONS treatments may limit their effectiveness, although this
is a parameter that is not always assessed. Moreover, other
nutritional interventions such as serving smaller and fortified
meals or between-meal snacks may also help improving the
nutritional intakes of hospitalized patients, particularly in the
elderly [54,55].
Given these findings and that the geriatric population rep-
resents a large proportion of patients hospitalized in medicalwards, as well as the consistent recommendations among
selected guidelines, ONS should be used in addition to hospital
meals ideally adapted to individual preferences to meet nutri-
tional requirements and improve outcomes of malnourished or
at-risk medical inpatients. Fortification of meals and providing
patients with between-meal snacks should be at least equally
part of the strategy to supplement intakes.Route, monitoring, and reassessment
Question 7. In malnourished or at-risk medical inpatients able to
consume food orally, does enteral tube feeding result in improved
outcomes when compared with oral nutrition?
Oral feeding constitutes the most physiological route of
feeding to correct DRM, but it is not always sufficient to treat
DRM and improve outcomes, especially in cases of acute
illness.
The supporting evidence we found to determine the
preferred way of feeding malnourished or at-risk medical in-
patients is limited to one RCT [56] conducted in acute pancrea-
titis patients where only one outcome (pain relapse following
oral or enteral refeeding) was measured and no difference was
found between both groups [56]. No data addressing the ques-
tion of how long oral nutrition should be implemented before
starting enteral tube feeding were found within the selected
ESPEN guidelines.
All selected guidelines recommend oral nutrition as the first
route of feeding for nutritional therapy of malnourished or at-
risk patients who are able to ingest food. When the nutritional
requirements cannot be met via this route during the recom-
mended 5 to 7 d (according to the majority of the guidelines,
although this period can be extended to 8 wk in chronic infec-
tious diseases), enteral tube feeding is recommended. In most
guidelines, the recommended route of feeding is a nasogastric
tube or a percutaneous endoscopic gastrostomy, for example,
when long-term tube feeding is required.
Based on ESPEN recommendations, on the observation that
body weight stabilizes in patients able to reach 75% of their
nutritional needs [57] and on our own clinical experience rather
than on supportive data, enteral tube feeding, ideally maintain-
ing some oral food intake, should be implemented in medical
inpatients with or at-risk of DRM who could not reach 75% of
their energy and protein targets (or consume more than 75% of
the food served daily) within 5 d of oral feeding and for whom
clinical judgment predicted that oral nutrition would not be
sufficient to improve nutritional intakes. Intakes should be
reassessed every 24 to 48 h.
Depending on how long enteral tube feeding is foreseen, both
nasogastric tube and percutaneous endoscopic gastrostomy are
possible routes. Unless enteral tube feeding provides more than
1500 kcal/d, a multivitamin and micronutrient supplementation
is needed to cover micronutrient needs.
Question 8. In malnourished or at-risk medical inpatients who
are not able to consume sufficient food, does parenteral nutrition
result in improved outcomes when compared with enteral
nutrition?
One meta-analysis compared enteral with parenteral nutri-
tion in 263 medical inpatients with acute pancreatitis [58].
Enteral nutrition resulted in reduced incidence of surgical in-
terventions and LOS, but no effects on mortality or non-
infectious complications were observed.
The recommendations provided in all selected guidelines
state that in patients with an intact gastrointestinal tract,
L. Bounoure et al. / Nutrition 32 (2016) 790–798 797parenteral nutrition should be seen as a last resource when pa-
tients cannot be fed sufficiently orally or enterally.
Although supportive evidence is missing, we also recom-
mend starting parenteral nutrition with a minimal oral or
enteral feeding when possible, if oral and/or enteral nutrition is
not possible or if at least 75% of energy and protein targets
have not been reached during the 5 d after the beginning of
enteral nutrition. Intakes should be reassessed every 24 to
48 h.
Discussion
The procedures for detecting and treating DRM suggested in
the present study should not be considered as providing robust
recommendations such as those developed in validated guide-
lines (ESPEN or from other societies) for several reasons:
1. Our suggestions were developed using evidence extracted
from selected current ESPEN disease- and medical specialty-
specific guidelines (Table 1). Therefore, we relied on the
studies identified and included by the authors of those guide-
lines rather than conducting a new systematic search of the
literature, with the possibility that several studies potentially
relevant to answering our clinical questions might have been
missed. Moreover, the guidelines used as a source of evidence
were updated for the last time at least 6 y ago, which conse-
quently resulted in the extraction of studies published until
2007. Studies conducted later than this were therefore not
captured and not used as evidence behind our questions.
2. The methodological quality and potential biases of the
studies we extracted from the selected guidelines were not
reassessed and were not taken in consideration when analyzing
their results. This may have led to over- or underestimation of
the effects of the interventions on the analyzed outcomes.
3. Due to limited evidence found to answer our questions, the
procedures we suggest are not only based on published studies,
but also take in consideration the recommendations given in the
ESPEN guidelines we selected, as well as expert opinions, based
on the clinical experience of the members of our working group.
4. Although the procedures suggested in this report are
intended to apply to any medical inpatient independent of un-
derlying disease, they do not exempt clinicians from identifying
particular groups of patients for which an adaptation is needed
to ensure optimal, clinically and ethically sound nutritional
support, such as in the management of acute pancreatitis or
patients in terminal conditions. A uniform nutritional strategy
suitable for all medical inpatients might also lack from precision
and might lead to a less sensitive effect compared to a more
targeted approach. Yet, due to the growing challenges of older
and frail medical inpatients, a pragmatic and integrated
approach may still be needed.
Conclusion
Although this work differs fromvalidated guidelines, wewere
able to develop and provide practical and simple guidance to
detect existing DRM as well as those patients at-risk of devel-
oping DRM and implement nutritional therapy in the heteroge-
neous population of medical inpatients. Our suggestions are
summarized in Table 2 and also graphically represented in the
form of a user-friendly nutritional algorithm (Fig. 1), which is
currently used to provide nutritional therapy inmedical wards of
several Swiss hospitals as part of a large multicenter RCT.
While this RCT includes the heterogeneous medical inpatient
population receiving nutritional therapy according to the hereindescribed practical procedures, it should be noted that particular
subgroups of patients requiring a specific nutritional therapy
approach are excluded from the trial (e.g., pancreatitis, terminal
patients), in accordance with the previously acknowledged lim-
itation of this study.Acknowledgments
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